Biotest AG
BTTAYOTCHealthcare
$24.23
+$0.00(+0.00%)
Market Cap$943029783
P/E Ratio—
52W High$24.27
52W Low$22.8
Biotest AG（BTTAY）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · BTTAY · 截至 Jun 8, 2026
关键指标
探索 Biotest AG 数据
bttay stock data · financials财务快照
完整财报FY 2024Revenue$726.2M▲ +6.08% YoY
202220232024
biotest ag revenue · bttay revenue 2024FY 2024Net Income$26.4M▼ 79.21% YoY
202220232024
biotest ag net income · bttay profit 2024FY 2024EPS$0.36▼ 77.50% YoY
202220232024
bttay eps · biotest ag earnings per share 2024竞争对手与同行
bttay competitors#TickerCompanyPriceChangeMkt Cap
#1BTTAYBiotest AG
$24.23+0.00%$943.0M#2
CKDXFOpthea Limited
$0.44+0.00%$601.9M#3
CLAZFClaritas Pharmaceuticals, Inc.
$0.00+0.00%$3,659#4
CSWYFChina Shineway Pharmaceutical Group Limited
$1.08+7.57%$815.8M#5
EBRCZEBR Systems, Inc.
$0.35-0.03%$262.3M#6
IVEVFInventiva S.A.
$4.00-24.95%$556.2M股票表现
完整历史1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD-0.16%
1Y-0.16%
5Y-0.16%
关于 Biotest AG
Biotest AG Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers…
what is biotest ag · bttay stock overview · biotest ag company profile · who is biotest ag ceo · bttay OTC · biotest ag headquarters · biotest ag business segments
关于股票概览与关键数据
Biotest AG（BTTAY）是 Biotechnology 行业的 Healthcare 类公司，于 Aug 8, 2022 在 OTC 上市。截至最近交易日，BTTAY 股价为 $24.23，市值约为 $943.0M。过去12个月累计回报 -0.16%，年初至今回报 -0.16%。
2024 财年 Biotest AG 营收 $726.2M。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。
常见问题
截至最近一个交易日，Biotest AG（BTTAY）股价为 $24.23，在 OTC 上市，52周区间为 $22.80 – $24.27。
BTTAY 最新股价BTTAY quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议